CT-guided Ganglion Impar Block for Management of Phantom Rectal Pain Syndrome
1 other identifier
interventional
40
1 country
1
Brief Summary
Background:Patients underwent abdominoperineal resection with colostomy may suffered from phantom rectum pain syndrome in the perineal area.In this study, the investigators evaluate the combination between ganglion impar block to pregabaline in the treatment of phantom rectal pain syndrome. Method: Forty patients were randomly allocated into 2 groups: Group A (n=20) where patients received pregabaline 150 mg twice daily. Group B (n=20) where patients received pregabaline 150 mg twice daily plus ganglion impar block using 5 ml bupivacaine 5% with 14 mg/2 ml betamethasone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2018
CompletedFirst Submitted
Initial submission to the registry
September 29, 2018
CompletedFirst Posted
Study publicly available on registry
October 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2019
CompletedMarch 7, 2019
March 1, 2019
12 months
September 29, 2018
March 6, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
numerical rating scale
from 0 to 10 as 0 no pain and 10 the worst pain
two months
Participant satisfaction reporting scale (PSRS)
it is 5 item self questionnaire1. How well was your pain problem explained to you during treatment?2. Did you agree with the types of treatments and recommendations that you received? 3. How satisfied were you with the care that you received in the Spine Care Center/ Anesthesiology Clinic? 4. Rate your overall improvement since starting treatment: 5. Rate your level of satisfaction with your improvement since starting treatment.
two months
Secondary Outcomes (3)
Number of participants with post block complication
2 hours
success rate of block
one week
Pain Anxiety symptoms scale (PASS).
one week
Study Arms (2)
Pregabaline group
NO INTERVENTIONwhere patients received pregabaline 150 mg twice daily.
Pregabaline plus ganglion impar block group
ACTIVE COMPARATORwhere patients received pregabaline 150 mg twice daily plus ganglion impar block using 5 ml bupivacaine 5% with 14 mg/2 ml betamethasone.
Interventions
CT sections were done in the axial plane 4 mm slice thickness to detect the site of sacrococcygeal disk. After a suitable section was confirmed, two distances were measured, one from patient's spine to the proper site of entry and the other from the site of entry to the target point.22 gauge spinal needle 12 cm was introduced until reach anterior to sacrococcygeal disk. When the needle tip location was ideal, 2 ml lidocaine mixed with1ml of radiopaque dye was injected. CT sagittal section was done to verify the retroperitoneal distribution of the dye. After good contrast spread confirmation, 5 ml bupivacaine 5% with 14 mg/2 ml betamethasone was injected
Eligibility Criteria
You may qualify if:
- complained from phantom rectal pain syndrome after abdominoperineal surgery for rectal cancer with colostomy.
You may not qualify if:
- those who refused to share
- evidence of local infection at the puncture site
- allergy to drugs used
- patients with bleeding tendency or coagulopathy, renal or hepatic failure, cardiac patients,
- bony abnormality and local malignant recurrence or lower vertebral metastasis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yahay wahba
Al Mansurah, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia
Study Record Dates
First Submitted
September 29, 2018
First Posted
October 3, 2018
Study Start
June 12, 2018
Primary Completion
June 1, 2019
Study Completion
July 29, 2019
Last Updated
March 7, 2019
Record last verified: 2019-03